Overview

Gender

male

Edward Stuart was the original founding CEO of CT Atlantic and brings significant experience in business development for biotechnology start-ups.

Stuart is a co-founder of HS LifeSciences and QureInvest and previously CEO of Neurimmune Therapeutics (Zurich, Switzerland). He was also a co-founder of U3 Pharma (Munich, Germany) and was its Managing Director and CBO from 2001 to 2007.

Stuart is a pharmacologist by training having received his PhD from University College Dublin, Ireland and holds an MBA from the Business School of Imperial College, London (London, UK).